With a market cap of has a large market cap size. Amgen Inc. (NASDAQ: AMGN) has been on the stock market since its IPO date on the 9/7/1984. Amgen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Amgen Inc., is 2805.7, and so far today it has a volume of 943103. Performance year to date since the 9/7/1984 is 1.46%.
To help you determine whether Amgen Inc. is undervalued the following values will help you decide. P/E is 17.19 and forward P/E is 13.32. PEG perhaps more useful shows that Amgen Inc. has a value for PEG of 2.03. P/S ratio is 5.52 and the P/B ratio is 4.27. The P/Cash and P/Free cash flow is 3.52 and 19.5 respectively.
At the current price Amgen Inc. is trading at, 163.42 (0.57% today), Amgen Inc. has a dividend yield of 2.46%, and this is covered by a payout ratio of 35.30%. Earnings per share (EPS) is 9.45, and this is looking to grow in the next year to 9.41% after growing 35.20% this past year. EPS growth quarter over quarter is 18.50%, and 9.80% for sales growth quarter over quarter.
The number of shares outstanding is 753, and the number of shares float is 750.35. The senior management bring insider ownership to 0.20%, and institutional ownership is at 81.30%. The float short is 1.04%, with the short ratio at a value of 2.78. Management has seen a return on assets of 10.00%, and also a return on investment of 12.50%.
The ability for Amgen Inc., to deal with debt, means it current ratio is 5, and quick ratio is 4.7. Long term debt/equity is 1.12 and total debt/equity is 1.2. In terms of margins, Amgen Inc. has a gross margin of 81.00%, with its operating margin at 39.90%, and Amgen Inc. has a profit margin of 32.60%.
The 52 week high is -8.01%, with 27.97% being its 52 week low. The 20 day simple moving average is 5.64% and the 200 day simple moving average is 6.90%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.